Silvia Biocca, PhD, Associate Professor of Clinical Biochemistry, has long-lasting experience in cell biology, immunotechnology, intracellular trafficking, and DNA nanotechnology. She has been involved for years in developing two biotechnological platforms, the intracellular antibody and the DNA nanocage strategies, both having direct applications in cancer therapy.